{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:22:32Z","timestamp":1793211752116,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015809","name":"Health Medical Collaborative Innovation Program of Guangzhou","doi-asserted-by":"publisher","award":["201704020214"],"award-info":[{"award-number":["201704020214"]}],"id":[{"id":"10.13039\/501100015809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670166"],"award-info":[{"award-number":["81670166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81621001"],"award-info":[{"award-number":["81621001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81530046"],"award-info":[{"award-number":["81530046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["BMU2019 LCKXJ003"],"award-info":[{"award-number":["BMU2019 LCKXJ003"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z171100001017098"],"award-info":[{"award-number":["Z171100001017098"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0104500"],"award-info":[{"award-number":["2017YFA0104500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clim.2021.108727","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T16:52:54Z","timestamp":1618937574000},"page":"108727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application"],"prefix":"10.1016","volume":"227","author":[{"given":"Wei","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2021.108727_bb0005","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3389\/fimmu.2018.02324","article-title":"Molecular mechanisms directing migration and retention of natural killer cells in human tissues","volume":"9","author":"Castriconi","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2021.108727_bb0010","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad Spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2021.108727_bb0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fimmu.2012.00347","article-title":"Natural killer cell distribution and trafficking in human tissues","volume":"3","author":"Carrega","year":"2012","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2021.108727_bb0020","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaci.2016.07.043","article-title":"Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69(\u2212)CD56(dim) cells","volume":"139","author":"Marquardt","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2021.108727_bb0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3799","article-title":"Balancing natural killer cell activation through paired receptors","volume":"15","author":"Martinet","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2021.108727_bb0030","doi-asserted-by":"crossref","first-page":"1586905","DOI":"10.1155\/2018\/1586905","article-title":"High-risk leukemia: past, present, and future role of NK cells","volume":"2018","author":"Mavers","year":"2018","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/v11030243","article-title":"Viral infection of human natural killer cells","volume":"11","author":"van Erp","year":"2019","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.clim.2021.108727_bb0040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molimm.2004.07.034","article-title":"Activation of NK cell cytotoxicity","volume":"42","author":"Smyth","year":"2005","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1081\/CNV-120001185","article-title":"Biology of natural killer cells in cancer and infection","volume":"20","author":"Miller","year":"2002","journal-title":"Cancer Investig."},{"key":"10.1016\/j.clim.2021.108727_bb0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.immuni.2015.02.013","article-title":"Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals","volume":"42","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2021.108727_bb0060","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fphar.2020.01309","article-title":"Harnessing memory NK cell to protect against COVID-19","volume":"11","author":"Soleimanian","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.clim.2021.108727_bb0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41590-018-0082-6","article-title":"Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells","volume":"19","author":"Hammer","year":"2018","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2021.108727_bb0070","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1182\/blood-2002-02-0350","article-title":"Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect","volume":"100","author":"Farag","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.clim.2021.108727_bb0075","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2011-04-347070","article-title":"NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions","volume":"118","author":"Foley","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0080","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2010-02-269381","article-title":"NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation","volume":"117","author":"Haas","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clim.2021.108727_bb0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.transproceed.2019.11.010","article-title":"CMV-reactive NK cells in pediatric post-hematopoietic stem cell transplant","volume":"52","author":"Apiwattanakul","year":"2020","journal-title":"Transplant. Proc."},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0090","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125553","article-title":"Adaptive NK cell reconstitution is associated with better clinical outcomes","volume":"4","author":"Cichocki","year":"2019","journal-title":"JCI Insight"},{"issue":"16","key":"10.1016\/j.clim.2021.108727_bb0095","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/bloodadvances.2019000298","article-title":"The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples","volume":"3","author":"Rashidi","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.clim.2021.108727_bb0100","first-page":"101","article-title":"Cmv1 and natural killer cell responses to murine cytomegalovirus infection","volume":"321","author":"Scalzo","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2021.108727_bb0105","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ni714","article-title":"Specific and nonspecific NK cell activation during virus infection","volume":"2","author":"Dokun","year":"2001","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2013.12.011","article-title":"Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection","volume":"40","author":"Nabekura","year":"2014","journal-title":"Immunity"},{"issue":"14","key":"10.1016\/j.clim.2021.108727_bb0115","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2012-10-459545","article-title":"NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs","volume":"121","author":"B\u00e9ziat","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","article-title":"Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function","volume":"42","author":"Schlums","year":"2015","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.clim.2021.108727_bb0125","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Gum\u00e1","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clim.2021.108727_bb0130","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.celrep.2016.04.005","article-title":"Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans","volume":"15","author":"Liu","year":"2016","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.clim.2021.108727_bb0135","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.4049\/jimmunol.1201964","article-title":"Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen","volume":"189","author":"Foley","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2021.108727_bb0140","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","article-title":"Tissue determinants of human NK cell development, function, and residence","volume":"180","author":"Dogra","year":"2020","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.clim.2021.108727_bb0145","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2017-05-785659","article-title":"Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation","volume":"130","author":"Ciurea","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clim.2021.108727_bb0150","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbmt.2014.01.006","article-title":"Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells","volume":"20","author":"Leong","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11904-016-0310-3","article-title":"NK cells in HIV disease","volume":"13","author":"Scully","year":"2016","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"13","key":"10.1016\/j.clim.2021.108727_bb0160","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/JVI.00256-09","article-title":"HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection","volume":"83","author":"Alter","year":"2009","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.clim.2021.108727_bb0165","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1084\/jem.20070695","article-title":"Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR\/HLA subtypes","volume":"204","author":"Alter","year":"2007","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.clim.2021.108727_bb0170","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1073\/pnas.071548198","article-title":"Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity","volume":"98","author":"Flores-Villanueva","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2021.108727_bb0175","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3389\/fimmu.2018.02290","article-title":"NK cells in HIV-1 infection: from basic science to vaccine strategies","volume":"9","author":"Fl\u00f3rez-\u00c1lvarez","year":"2018","journal-title":"Front. Immunol."},{"issue":"6288","key":"10.1016\/j.clim.2021.108727_bb0180","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo","volume":"352","author":"Lu","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.clim.2021.108727_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001999","article-title":"Anti-HIV activity mediated by natural killer and CD8+ cells after toll-like receptor 7\/8 triggering","volume":"3","author":"Schlaepfer","year":"2008","journal-title":"PLoS One"},{"issue":"6857","key":"10.1016\/j.clim.2021.108727_bb0190","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.clim.2021.108727_bb0195","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/cid\/cix201","article-title":"Short-course toll-like receptor 9 agonist treatment impacts innate immunity and plasma Viremia in individuals with human immunodeficiency virus infection","volume":"64","author":"Vibholm","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.clim.2021.108727_bb0200","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.4049\/jimmunol.171.11.5663","article-title":"Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users","volume":"171","author":"Scott-Algara","year":"2003","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0205","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.clim.2006.02.008","article-title":"Increased IFN-gamma production by NK and CD3+\/CD56+ cells in sexually HIV-1-exposed but uninfected individuals","volume":"120","author":"Montoya","year":"2006","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2021.108727_bb0210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0092-8674(00)81429-4","article-title":"Chemokine receptors: keys to AIDS pathogenesis?","volume":"93","author":"Littman","year":"1998","journal-title":"Cell"},{"issue":"6584","key":"10.1016\/j.clim.2021.108727_bb0215","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/381667a0","article-title":"HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5","volume":"381","author":"Dragic","year":"1996","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.clim.2021.108727_bb0220","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1084\/jem.186.10.1793","article-title":"Signal transduction due to HIV-1 envelope interactions with chernokine receptors CXCR4 or CCR5","volume":"186","author":"Davis","year":"1997","journal-title":"J. Exp. Med."},{"issue":"6654","key":"10.1016\/j.clim.2021.108727_bb0225","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/40173","article-title":"Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor","volume":"389","author":"Weissman","year":"1997","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.clim.2021.108727_bb0230","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1073\/pnas.95.7.3857","article-title":"C-C chemokines, pivotal in protection against HIV type 1 infection","volume":"95","author":"Zagury","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5243","key":"10.1016\/j.clim.2021.108727_bb0235","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1\u03b1, and MIP-1\u03b2 as the major HIV-suppressive factors produced by CD8+ T cells","volume":"270","author":"Cocchi","year":"1995","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.clim.2021.108727_bb0240","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4049\/jimmunol.178.1.407","article-title":"IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction","volume":"178","author":"Miss\u00e9","year":"2007","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2021.108727_bb0245","first-page":"94","article-title":"Presence of inflammatory group i and iii innate lymphoid cells in the colon of simian immunodeficiency virus-infected Rhesus Macaques","author":"Cogswell","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2021.108727_bb0250","doi-asserted-by":"crossref","first-page":"387950","DOI":"10.1155\/2014\/387950","article-title":"The secretion of IL-22 from mucosal NKp44+ NK cells is associated with microbial translocation and virus infection in SIV\/SHIV-infected Chinese macaques","volume":"2014","author":"Wang","year":"2014","journal-title":"J Immunol Res"},{"issue":"9","key":"10.1016\/j.clim.2021.108727_bb0255","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ni.3227","article-title":"Antigen-specific NK cell memory in rhesus macaques","volume":"16","author":"Reeves","year":"2015","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108727_bb0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/imm.12898","article-title":"Origins of natural killer cell memory: special creation or adaptive evolution","volume":"154","author":"Holder","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2021.108727_bb0265","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.smim.2017.07.011","article-title":"Natural killer cells unleashed: checkpoint receptor blockade and BiKE\/TriKE utilization in NK-mediated anti-tumor immunotherapy","volume":"31","author":"Davis","year":"2017","journal-title":"Semin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2021.108727_bb0270","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.4049\/jimmunol.162.5.2606","article-title":"IL-15 induces the expression of chemokines and their receptors in T lymphocytes","volume":"162","author":"Perera","year":"1999","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2021.108727_bb0275","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1172\/JCI118726","article-title":"Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines","volume":"97","author":"Bluman","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2021.108727_bb0280","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0065-2776(04)86006-1","article-title":"Interleukin-2, interleukin-15, and their roles in human natural killer cells","volume":"86","author":"Becknell","year":"2005","journal-title":"Adv. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2021.108727_bb0285","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/JLB.MR0718-303R","article-title":"Adaptive NK cell responses in HIV\/SIV infections: a roadmap to cell-based therapeutics?","volume":"105","author":"Ram","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0290","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAD.0b013e32833424c8","article-title":"Targeting Trojan horse leukocytes for HIV prevention","volume":"24","author":"Anderson","year":"2010","journal-title":"Aids"},{"issue":"12","key":"10.1016\/j.clim.2021.108727_bb0295","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00235-18","article-title":"Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo","volume":"92","author":"Garrido","year":"2018","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.clim.2021.108727_bb0300","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0040027","article-title":"Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma","volume":"4","author":"Strowig","year":"2008","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.clim.2021.108727_bb0310","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.4049\/jimmunol.1301046","article-title":"A distinct subpopulation of human NK cells restricts B cell transformation by EBV","volume":"191","author":"L\u00fcnemann","year":"2013","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0315","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","article-title":"The immune response to primary EBV infection: a role for natural killer cells","volume":"129","author":"Williams","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.clim.2021.108727_bb0320","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.celrep.2013.11.041","article-title":"Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection","volume":"5","author":"Chijioke","year":"2013","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.clim.2021.108727_bb0325","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.4049\/jimmunol.1303211","article-title":"Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus","volume":"192","author":"Hendricks","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108727_bb0330","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/TP.0000000000002941","article-title":"Alterations in NKG2A and NKG2C subsets of natural killer cells following Epstein-Barr virus reactivation in CTLA4Ig-based Haploidentical transplantation is associated with increased chronic graft-versus-host disease","volume":"104","author":"Jaiswal","year":"2020","journal-title":"Transplantation"},{"issue":"16","key":"10.1016\/j.clim.2021.108727_bb0335","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","article-title":"Role for early-differentiated natural killer cells in infectious mononucleosis","volume":"124","author":"Azzi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clim.2021.108727_bb0340","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fimmu.2016.00323","article-title":"NK cell influence on the outcome of primary Epstein-Barr virus infection","volume":"7","author":"Chijioke","year":"2016","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2021.108727_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005286","article-title":"The incubation period of primary Epstein-Barr virus infection: viral dynamics and immunologic events","volume":"11","author":"Dunmire","year":"2015","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.clim.2021.108727_bb0350","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.immuni.2015.09.013","article-title":"Natural killer cell memory","volume":"43","author":"O\u2019Sullivan","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.clim.2021.108727_bb0355","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.18632\/oncotarget.14045","article-title":"Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-\u03b3","volume":"8","author":"Jud","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0360","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/JVI.01777-06","article-title":"The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing","volume":"81","author":"Pappworth","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2021.108727_bb0365","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.oraloncology.2018.07.011","article-title":"Cellular-based immunotherapy in Epstein-Barr virus induced nasopharyngeal cancer","volume":"84","author":"Lee","year":"2018","journal-title":"Oral Oncol."},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0370","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01281-09","article-title":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4+ T cells are important in control of SARS-CoV infection","volume":"84","author":"Chen","year":"2010","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.clim.2021.108727_bb0375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/QAD.0b013e3283328d1f","article-title":"Chronic HIV-1 viremia reverses NKG2A\/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection","volume":"24","author":"Brunetta","year":"2010","journal-title":"Aids"},{"key":"10.1016\/j.clim.2021.108727_bb0380","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coviro.2015.10.008","article-title":"Roles of natural killer cells in antiviral immunity","volume":"16","author":"Waggoner","year":"2016","journal-title":"Curr. Opin. Virol."},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0385","doi-asserted-by":"crossref","first-page":"100016","DOI":"10.1016\/j.xcrm.2020.100016","article-title":"Adjunct immunotherapies for the Management of Severely ill COVID-19 patients","volume":"1","author":"Bonam","year":"2020","journal-title":"Cell Rep. Med."},{"issue":"7815","key":"10.1016\/j.clim.2021.108727_bb0390","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.clim.2021.108727_bb0395","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1309\/WPK7Y2XKNF4CBF3R","article-title":"The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome","volume":"121","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0400","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41423-020-00557-9","article-title":"Unique immunological profile in patients with COVID-19","volume":"18","author":"Varchetta","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108727_bb0405","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1196\/annals.1373.014","article-title":"Porcine innate and adaptative immune responses to influenza and coronavirus infections","volume":"1081","author":"Charley","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.clim.2021.108727_bb0410","doi-asserted-by":"crossref","first-page":"102561","DOI":"10.1016\/j.autrev.2020.102561","article-title":"Fatal COVID-19 infections: is NK cell dysfunction a link with autoimmune HLH?","volume":"19","author":"Osman","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0415","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-gamma-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.clim.2021.108727_bb0420","first-page":"99","article-title":"Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis","volume":"2","author":"Li","year":"2021","journal-title":"Med. (N. Y.)"},{"issue":"6","key":"10.1016\/j.clim.2021.108727_bb0425","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2021.108727_bb0430","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3389\/fimmu.2019.01457","article-title":"Influenza and antibody-dependent cellular cytotoxicity","volume":"10","author":"Von Holle","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2021.108727_bb0435","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2021.108727_bb0440","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137799","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.clim.2021.108727_bb0445","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-08-3712","article-title":"Expansion of highly cytotoxic human natural killer cells for cancer cell therapy","volume":"69","author":"Fujisaki","year":"2009","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0450","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clim.2021.108727_bb0455","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3389\/fimmu.2019.01205","article-title":"Cancer immunotherapy based on natural killer cells: current Progress and new opportunities","volume":"10","author":"Hu","year":"2019","journal-title":"Front. Immunol."},{"issue":"20","key":"10.1016\/j.clim.2021.108727_bb0460","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0465","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","article-title":"Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice","volume":"144","author":"Li","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0470","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.smim.2014.02.007","article-title":"NK cell self tolerance, responsiveness and missing self recognition","volume":"26","author":"Shifrin","year":"2014","journal-title":"Semin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2021.108727_bb0475","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/hep.26115","article-title":"Natural killer cells in liver disease","volume":"57","author":"Tian","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clim.2021.108727_bb0480","doi-asserted-by":"crossref","first-page":"2","DOI":"10.20411\/pai.v3i1.228","article-title":"ADCC-mediated CD56(DIM) NK cell responses are associated with early HBsAg clearance in acute HBV infection","volume":"3","author":"Yu","year":"2018","journal-title":"Pathog. Immun."},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0485","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jhep.2018.11.009","article-title":"HCMV jogs the \u2018memory\u2019 of NK cells in HBV","volume":"70","author":"Gill","year":"2019","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0490","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/hep.21872","article-title":"Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells","volume":"46","author":"Chen","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0495","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/hep.21872","article-title":"Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells","volume":"46","author":"Chen","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clim.2021.108727_bb0500","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/hep.23253","article-title":"Major histocompatibility complex class I-related chains A and B (MIC A\/B): a novel role in nonalcoholic steatohepatitis","volume":"51","author":"Kahraman","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0505","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0510","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2009.05.030","article-title":"Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C","volume":"51","author":"Bonorino","year":"2009","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002594","article-title":"TGF-\u03b21 down-regulation of NKG2D\/DAP10 and 2B4\/SAP expression on human NK cells contributes to HBV persistence","volume":"8","author":"Sun","year":"2012","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0520","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.clim.2008.08.012","article-title":"Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients","volume":"129","author":"Cai","year":"2008","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108727_bb0525","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humimm.2019.11.006","article-title":"Impaired circulating CD56(dim) NK cells are associated with decompensation of HBV-related cirrhosis","volume":"81","author":"Jiang","year":"2020","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2021.108727_bb0530","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2017.01.007","article-title":"NK cell phenotypic and functional shifts coincide with specific clinical phases in the natural history of chronic HBV infection","volume":"140","author":"de Groen","year":"2017","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0535","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/j.gastro.2009.05.047","article-title":"Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections","volume":"137","author":"Oliviero","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clim.2021.108727_bb0540","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.21073","article-title":"Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing","volume":"43","author":"Morishima","year":"2006","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.clim.2021.108727_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205080","article-title":"The good and the bad of natural killer cells in virus control: perspective for Anti-HBV therapy","volume":"20","author":"Fisicaro","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.clim.2021.108727_bb0550","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02105-17","article-title":"Herpesvirus evasion of natural killer cells","volume":"92","author":"De Pelsmaeker","year":"2018","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.clim.2021.108727_bb0555","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41590-018-0163-6","article-title":"Natural killer cell specificity for viral infections","volume":"19","author":"Hammer","year":"2018","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2021.108727_bb0560","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/v8040095","article-title":"Viral evasion of natural killer cell activation","volume":"8","author":"Ma","year":"2016","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0565","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2015.07.012","article-title":"BNIP3- and BNIP3L-mediated Mitophagy promotes the generation of natural killer cell memory","volume":"43","author":"O\u2019Sullivan","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2021.108727_bb0570","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.virol.2015.03.042","article-title":"Viruses and the autophagy pathway","volume":"479-480","author":"Jackson","year":"2015","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.clim.2021.108727_bb0575","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.stem.2018.06.002","article-title":"Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity","volume":"23","author":"Li","year":"2018","journal-title":"Cell Stem Cell"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:03:56Z","timestamp":1761494636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":115,"alternative-id":["S1521661621000644"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108727","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108727"}}